Published in Virology on February 01, 2000
Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol (2005) 2.24
A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol (2009) 2.20
Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J Virol (2005) 1.25
Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol (2008) 1.12
Distribution of HBV genotypes among HBV carriers in Benin:phylogenetic analysis and virological characteristics of HBV genotype E. World J Gastroenterol (2005) 0.89
Hepatitis B precore protein: pathogenic potential and therapeutic promise. Yonsei Med J (2012) 0.86
Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles. J Virol (2014) 0.83
Species association of hepatitis B virus (HBV) in non-human apes; evidence for recombination between gorilla and chimpanzee variants. PLoS One (2012) 0.82
Detection of Hepatitis B virus in serum and liver of chickens. Virol J (2012) 0.81
Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8+ T cell responses against a HBV DNA vaccine in mice. Hum Vaccin Immunother (2013) 0.80
Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus. J Virol (2014) 0.77
Hepatitis B virus lineages in mammalian hosts: potential for bidirectional cross-species transmission. World J Gastroenterol (2014) 0.76
Resolving ambiguity in the phylogenetic relationship of genotypes A, B, and C of hepatitis B virus. BMC Evol Biol (2013) 0.75
Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysis. PLoS One (2013) 0.75
An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A (1968) 7.33
Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology (1992) 5.16
On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med (1975) 4.11
Serum hepatitis antigen (SH): rapid detection by high voltage immunoelectroosmophoresis. Science (1970) 4.00
Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet (1995) 3.99
Immunochemical structure of hepatitis B e antigen in the serum. J Immunol (1983) 3.50
Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci U S A (1991) 3.34
Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology (1992) 3.22
Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol (1993) 2.90
The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol (1974) 2.85
Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet (1974) 2.77
Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region. Jpn J Exp Med (1990) 2.72
Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide. Proc Natl Acad Sci U S A (1982) 2.52
Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc Natl Acad Sci U S A (1988) 2.47
Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med (1994) 2.38
Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology (1992) 2.37
Switch circular DNA formed in cytokine-treated mouse splenocytes: evidence for intramolecular DNA deletion in immunoglobulin class switching. Cell (1990) 2.30
Immunity in hepatitis C infection. J Infect Dis (1992) 2.28
Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet (1992) 2.25
Immunologic distinction between infectious and serum hepatitis. N Engl J Med (1970) 2.16
A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med (1971) 2.02
Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology (1995) 2.00
Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. JAMA (1974) 1.92
A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology (1993) 1.90
A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology (1984) 1.90
Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis-B antigen. Lancet (1973) 1.89
Role of serum hepatitis virus in chronic liver disease. Gastroenterology (1971) 1.84
p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts. Virology (1992) 1.84
Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey. J Virol (1991) 1.82
Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci U S A (1994) 1.81
Relation of Australia and SH antigens. Lancet (1968) 1.75
Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance. Gut (1976) 1.74
A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci U S A (1986) 1.74
Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing. Vaccine (1986) 1.68
Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med (1975) 1.66
The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol (1995) 1.64
Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. Proc Natl Acad Sci U S A (1989) 1.64
Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection. J Infect Dis (1993) 1.63
Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol (1997) 1.63
Hyoscyamine 6 beta-hydroxylase, an enzyme involved in tropane alkaloid biosynthesis, is localized at the pericycle of the root. J Biol Chem (1991) 1.62
Familial clustering of hepatitis B infection. N Engl J Med (1973) 1.56
Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J Gen Virol (1992) 1.56
Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus. Arch Virol (2000) 1.54
HMG1-related DNA-binding protein isolated with V-(D)-J recombination signal probes. Mol Cell Biol (1991) 1.53
S.H. antigen and chronic liver disease. Lancet (1970) 1.51
A 49,000-dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22-nm hepatitis B surface antigen particles. J Immunol (1980) 1.50
Immunoglobulin switch circular DNA in the mouse infected with Nippostrongylus brasiliensis: evidence for successive class switching from mu to epsilon via gamma 1. Proc Natl Acad Sci U S A (1990) 1.49
Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci (1977) 1.48
Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin. Nature (1991) 1.47
Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol (1998) 1.47
Hepatitis B antigen and antibody in blood donors: an epidemiologic study. J Infect Dis (1973) 1.46
The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology (1992) 1.46
A redox factor protein, ref1, is involved in negative gene regulation by extracellular calcium. J Biol Chem (1994) 1.46
The use of tri(n-butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation. Transfusion (1990) 1.45
Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats. Psychopharmacology (Berl) (1990) 1.45
Gamma-glutamyltransferase as a potential surrogate marker for detection of the non-A, non-B carrier state. Vox Sang (1988) 1.44
The epidemiology of hepatitis B infections in Africa: results of a pilot survey in the Republic of Senegal. Am J Epidemiol (1973) 1.43
Prevalence of serum-hepatitis-related antigen (SH) in different geographic regions. Am J Trop Med Hyg (1970) 1.42
Sounding board. Use of hepatitis B immuneglobulin:reassessment needed. N Engl J Med (1978) 1.40
The epidemiology of serum hepatitis (SH) infections: a controlled study in two closed institutions. Am J Epidemiol (1971) 1.40
Virulent HIV strains, chimpanzees, and trial vaccines. Science (1999) 1.40
Virus-like particles in human plasma and serum: role of platelet lysosomes. J Natl Cancer Inst (1966) 1.39
Prevalence, clinical significance, and strain specificity of neutralizing antibody to the human immunodeficiency virus. J Infect Dis (1987) 1.38
Production of albumin and other serum proteins by clonal cultures of normal human liver. Proc Natl Acad Sci U S A (1971) 1.38
The development of virus-free labile blood derivatives--a review. Eur J Epidemiol (1987) 1.33
Molecular cloning and characterization of onchocystatin, a cysteine proteinase inhibitor of Onchocerca volvulus. J Biol Chem (1992) 1.33
Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa. Lancet (1971) 1.30
Clinical signs of the pseudoexfoliation syndrome. Ophthalmology (1986) 1.29
Serum hepatitis specific antigen (SH) in commercial and volunteer sources of blood. Transfusion (1971) 1.29
Development and distribution of hemagglutinating antibody against the hepatitis B antigen in institutionalized populations. J Infect Dis (1972) 1.28
Hepatitis B antigen in wild-caught mosquitoes in Africa. Lancet (1972) 1.27
Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen. J Gen Virol (1976) 1.25
Preclinical diagnosis of pseudoexfoliation syndrome. Arch Ophthalmol (1987) 1.25
A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal. Int J Cancer (1975) 1.24
Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology (1992) 1.24
Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology (1994) 1.24
Full-genome nucleotide sequence of a hepatitis E virus strain that may be indigenous to Japan. Virology (2001) 1.24
Complete circular DNA genome of a TT virus variant (isolate name SANBAN) and 44 partial ORF2 sequences implicating a great degree of diversity beyond genotypes. Virology (1999) 1.24
Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reaction. Hepatology (1991) 1.23
Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. Blood (1992) 1.22
Three different patterns of hepatitis C virus infection in chimpanzees. Hepatology (1992) 1.21
Genetic heterogeneity of hepatitis C virus. Intervirology (1994) 1.19
Hypericin as an inactivator of infectious viruses in blood components. Transfusion (1995) 1.19
Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93). Arzneimittelforschung (1976) 1.18
Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci U S A (1991) 1.18
Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts. Placenta (2003) 1.17
Prevalence, genotypes, and an isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease. J Med Virol (1993) 1.17
Role of arthropods in transmission of hepatitis-B virus in the tropics. Lancet (1973) 1.17